Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (6 quarters reported)
$58.4M in Q2 2013 → — now. Hover for any quarter.
As reported for the quarter ended September 30, 2014. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| SM Select Med Hldgs Corp | NaN% | Unchanged | 0 | — |
| Jazz Pharmaceuticals PLC | NaN% | Unchanged | 0 | — |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 5 quarters.
quarter ended September 30, 2014 · filed October 30, 2014
No position changes this quarter.
quarter ended June 30, 2014 · filed July 29, 2014
No position changes this quarter.
quarter ended March 31, 2014 · filed May 08, 2014
No position changes this quarter.
quarter ended December 31, 2013 · filed February 12, 2014
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Jazz Pharmaceuticals PLC | Exited | −357,230 | −$32.9M | — |
| SM Select Med Hldgs Corp | Trimmed | −3,271,062 | — | — |
| Jazz Pharmaceuticals PLC | New | +0 | — | — |
quarter ended September 30, 2013 · filed October 23, 2013
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Jazz Pharmaceuticals PLC | Trimmed | −101,900 | −$9.37M | 55.4% |
Loading...
